Showing results (21-30 of 263) with videos related to
Sort By:
Pageof 27
Rheumatology (Oxford, England)|April 28, 2012
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practiceLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.Arthritis and Rheumatism|August 1, 2009
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatmentLisa K Stamp, John L O'Donnell, Peter T Chapman, et al.Current Opinion in Rheumatology|December 8, 2016
Major unanswered questions in the clinical gout fieldLisa K StampCurrent Opinion in Rheumatology|January 1, 2014
Safety profile of anti-gout agents: an updateLisa K StampArthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.Pathology|May 7, 2014
Comparison of two plasma urate assays in patients receiving vitamin C supplementationChristiaan W Sies, Christopher M Florkowski, Christopher M A Frampton, et al.Pathology|April 25, 2007
Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISAJohn L O'Donnell, Matthew W Hayman, Myfanwy B Spellerberg, et al.Pageof 27